Arthurian Life Sciences logo

Arthurian Life Sciences

Europe, England, United Kingdom, London

Description

Arthurian Life Sciences Ltd is an investment manager specialising in the life sciences sector.

Investor Profile

Arthurian Life Sciences has made 8 investments, with 0 in the past 12 months and 50% as lead.

Stage Focus

  • Post Ipo Equity (38%)
  • Series B (13%)
  • Series C (13%)
  • Seed (13%)
  • Series E (13%)
  • Series Unknown (13%)

Country Focus

  • United Kingdom (75%)
  • Switzerland (13%)
  • United States (13%)

Industry Focus

  • Health Care
  • Medical
  • Medical Device
  • Biotechnology
  • Therapeutics
  • Pharmaceutical
  • Hardware
  • Hospital
  • Oncology
  • Manufacturing
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Arthurian Life Sciences frequently co-invest with?

OrbiMed
North America, New York, United States, New York
Co-Investments: 1
Abingworth
Europe, England, United Kingdom, London
Co-Investments: 1
Limburgse Reconversie Maatschappij
Europe, Limburg, Belgium, Hasselt
Co-Investments: 1
New Enterprise Associates
North America, California, United States, Menlo Park
Co-Investments: 1
Andera Partners
Europe, Ile-de-France, France, Paris
Co-Investments: 1
PMV Pharmaceuticals
North America, California, United States, Redwood City
Co-Investments: 1
Novo Ventures
Europe, Hovedstaden, Denmark, Bagsværd
Co-Investments: 1
Novo Holdings
Europe, Hovedstaden, Denmark, Hellerup
Co-Investments: 1
Vivo Capital
North America, California, United States, Palo Alto
Co-Investments: 1
Aisling Capital
North America, New York, United States, New York
Co-Investments: 1

What are some of recent deals done by Arthurian Life Sciences?

Verona Pharma

London, England, United Kingdom

Verona Pharma is a biotechnology company dedicated to discovering new drugs for the treatment of chronic respiratory diseases.

BiotechnologyPharmaceuticalTherapeutics
Post Ipo EquityJun 20, 2016
Amount Raised: $65,627,780
Rutherford Health

Cardiff, Cardiff, United Kingdom

Rutherford Health is provides proton beam therapy/radiotherapy services for cancer treatment.

Health CareHospitalOncologyTherapeutics
SeedJan 1, 2016
Apitope

Bristol, Bristol, City of, United Kingdom

Apitope is a European biotech company

BiotechnologyHealth CareMedical
Series BSep 29, 2015
Amount Raised: $13,507,444
CeQur Simplicity

Horw, Luzern, Switzerland

CeQur Simplicity develops drug delivery devices.

Health CareMedicalMedical Device
Series CSep 1, 2015
Amount Raised: $100,000,000
Sphere Medical Holding

Cambridge, Cambridgeshire, United Kingdom

Sphere Medical Holding develops and commercializes monitoring products for critical care environments.

HardwareHealth CareMedical Device
Post Ipo EquityApr 21, 2015
Amount Raised: $19,404,665
Interrad Medical

Plymouth, Minnesota, United States

Interrad Medical develops innovative medical devices for use in minimally invasive interventional and surgical procedures.

Health CareManufacturingMedicalMedical Device
Series EDec 1, 2014
Amount Raised: $7,500,000
MedaPhor

Cardiff, Cardiff, United Kingdom

MedaPhor - Intelligent ultrasound simulation and AI software platforms.

EdTechEducationHealth CareHealth DiagnosticsInternetMedicalMedical Device
Series UnknownAug 19, 2014
Amount Raised: $7,810,656
ReNeuron Group

Guildford, Surrey, United Kingdom

ReNeuron Group is a proprietary stem cell based exosome technologies company.

BiotechnologyHealth CareMedicalTherapeutics
Post Ipo EquityJul 22, 2013
Amount Raised: $38,873,154